Figure 3.

Receiver Operating Characteristic (ROC) curves for SUMO1P3 (A), UCA1 (B), and the combination of SUMO1P3 and UCA1 (C) levels, detected in urines from bladder cancer patients, predicting the aggressive tumor phenotypes. ROC curve analyses were performed using the low-grade NMIBC samples as controls and the high-grade NMIBC (black) or the MIBC samples (magenta) as cases. On each graph, the corresponding area under the ROC Curve (AUC) is indicated. The gray rectangle highlights the area in which the specificity of the test is >90%.